Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Identification of Risk Allels for Prostate Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00323388
Recruitment Status : Completed
First Posted : May 9, 2006
Last Update Posted : January 7, 2010
Sponsor:
Information provided by:
University of New Mexico

Brief Summary:
Identification of Risk Allels for Prostate Cancer

Condition or disease
Prostate Cancer

Detailed Description:
As above.

Layout table for study information
Study Type : Observational
Official Title: Identification of Risk Allels for Prostate Cancer
Study Start Date : November 2005
Actual Primary Completion Date : September 2007
Actual Study Completion Date : September 2007

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Prostate Cancer





Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   Male
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients with prostate cancer
Criteria

Inclusion Criteria:

  • Patients with prostate cancer.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00323388


Locations
Layout table for location information
United States, New Mexico
University of New Mexico
Albuquerque, New Mexico, United States, 87131
Sponsors and Collaborators
University of New Mexico
Investigators
Layout table for investigator information
Principal Investigator: John Scariano University of New Mexico
Layout table for additonal information
Responsible Party: John Scariano; Principal Investigator, Universtiy of New Mexico
ClinicalTrials.gov Identifier: NCT00323388    
Other Study ID Numbers: HRRC 04-458
First Posted: May 9, 2006    Key Record Dates
Last Update Posted: January 7, 2010
Last Verified: November 2009
Additional relevant MeSH terms:
Layout table for MeSH terms
Prostatic Neoplasms
Genital Neoplasms, Male
Urogenital Neoplasms
Neoplasms by Site
Neoplasms
Prostatic Diseases